All In MedTech

Device Trial Radar · NCT07207239

Effect of Theta-burst rTMS Therapy on the Clinical and Cognitive Symptoms of Patients With Therapy Resistant Depression and Response Prediction With Neuroimaging Methods.

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

54

Planned (sponsor's estimate)

Start

Jun 13, 2025

Primary completion

Jun 13, 2028

Study completion Jun 13, 2028

Sponsor

Lead sponsor
Semmelweis UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 3, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Screening
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary aim of the study is to find the combination of neuroimaging-related markers, demographics, and clinical characteristics that predict the response of patients with therapy-resistant depression to theta-burst rTMS treatment. The secondary aim is to monitor the cognitive effects of TMS therapy.

Conditions

  • Transcranial Magnetic Stimulation, Repetitive
  • Depression - Major Depressive Disorder

Interventions

  • repetative Transcranial Magnetic Stimulation (rTMS), theta-burst protocolDevice

    Theta-burst rTMS treatment stimulates the left Dorsolateral Prefrontal Cortex (DLPFC). The TBS parameters the investigators adopted follows the standard TBS protocols, with 3-pulse 50-Hz bursts given every 200 ms (at 5 Hz) and an intensity of 100% active motor threshold. The investigators plan to deliver 1800 stimuli to the left DLPFC daily in 9.5-minute blocks for four weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical symptomsTime frame: 120 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Psychiatry and Psychotherapy

    Budapest, Pest County, Hungary · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.